A
Ascendis Pharma A/S
Q3 2025 earnings expected
Quarter
Jul – Sep
Expected
November 14, 2025(ET)
Revenue
This quarter$34M
Analyst estimate$214M▼ -84.3%
Year ago (Sep '24)$64M▼ -47.9%
EPS
This quarter-$1.17
Analyst estimate-$0.24
Year ago (Sep '24)-$1.81▲ +35.5%
Verifying this figure against consensus
Revenue Growth Trajectory
-65%YoY
Last 7 quarters